Malaria Journal (Mar 2012)

Genetic polymorphism and natural selection of Duffy binding protein of <it>Plasmodium vivax </it>Myanmar isolates

  • Ju Hye-Lim,
  • Kang Jung-Mi,
  • Moon Sung-Ung,
  • Kim Jung-Yeon,
  • Lee Hyeong-Woo,
  • Lin Khin,
  • Sohn Woon-Mok,
  • Lee Jin-Soo,
  • Kim Tong-Soo,
  • Na Byoung-Kuk

DOI
https://doi.org/10.1186/1475-2875-11-60
Journal volume & issue
Vol. 11, no. 1
p. 60

Abstract

Read online

Abstract Background Plasmodium vivax Duffy binding protein (PvDBP) plays an essential role in erythrocyte invasion and a potential asexual blood stage vaccine candidate antigen against P. vivax. The polymorphic nature of PvDBP, particularly amino terminal cysteine-rich region (PvDBPII), represents a major impediment to the successful design of a protective vaccine against vivax malaria. In this study, the genetic polymorphism and natural selection at PvDBPII among Myanmar P. vivax isolates were analysed. Methods Fifty-four P. vivax infected blood samples collected from patients in Myanmar were used. The region flanking PvDBPII was amplified by PCR, cloned into Escherichia coli, and sequenced. The polymorphic characters and natural selection of the region were analysed using the DnaSP and MEGA4 programs. Results Thirty-two point mutations (28 non-synonymous and four synonymous mutations) were identified in PvDBPII among the Myanmar P. vivax isolates. Sequence analyses revealed that 12 different PvDBPII haplotypes were identified in Myanmar P. vivax isolates and that the region has evolved under positive natural selection. High selective pressure preferentially acted on regions identified as B- and T-cell epitopes of PvDBPII. Recombination may also be played a role in the resulting genetic diversity of PvDBPII. Conclusions PvDBPII of Myanmar P. vivax isolates displays a high level of genetic polymorphism and is under selective pressure. Myanmar P. vivax isolates share distinct types of PvDBPII alleles that are different from those of other geographical areas. These results will be useful for understanding the nature of the P. vivax population in Myanmar and for development of PvDBPII-based vaccine.

Keywords